Lataa...
4CPS-175 Safe use of levetiracetam at doses higher than the maximum recommended
BACKGROUND: Levetiracetam (LEV) is a second-generation antiepileptic drug used as a unique or adjunctive therapy for treating partial or generalised epilepsy. Its maximum dose according to the summary product is 3000 mg/day. In patients with resistant epilepsy sometimes it is used at doses higher th...
Tallennettuna:
| Julkaisussa: | Eur J Hosp Pharm |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Group
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535336/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.265 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|